Filing Flows › Phibro Animal Health (PAHC) › Guidance history
Phibro Animal Health (PAHC) guidance history: what it guided and what it reported
Phibro Animal Health gave guidance in 3 earnings releases on file since May 6, 2026. Of 1 guided period since reported, it met or beat its own guidance once (100%). Revenue: 1 of 1, on average +2.6% against the guided midpoint. Its releases raised guidance once and lowered it once.
Revenue
Met or beat 1 of 1 periods (1 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | $1.6B–$1.6B (Aug 26, 2026) → reaffirmed $1.6B–$1.6B (Nov 4, 2026) | — | to be reported | — |
| FY26 | $1.5B–$1.5B (May 6, 2026) | $1.5B | above the range | +2.6% |
Adjusted revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | $1.6B–$1.6B (Nov 4, 2026) | — | to be reported | — |
Adjusted net income
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | $140M–$147M (Aug 26, 2026) → reaffirmed $140M–$147M (Nov 4, 2026) | — | to be reported | — |
| FY26 | $122M–$127M (May 6, 2026) | — | — | — |
Adjusted tax rate
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | 20.0% (Aug 26, 2026) → reaffirmed 20.0% (Nov 4, 2026) | — | to be reported | — |
| FY26 | 25.0% (May 6, 2026) | — | — | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | $258M–$268M (Aug 26, 2026) → reaffirmed $258M–$268M (Nov 4, 2026) | — | to be reported | — |
| FY26 | $247M–$255M (May 6, 2026) | — | — | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY27 | $3.41–$3.59 (Aug 26, 2026) → reaffirmed $3.41–$3.59 (Nov 4, 2026) | — | to be reported | — |
| FY26 | $2.98–$3.10 (May 6, 2026) | — | — | — |
The latest quarter
Phibro Animal Health, Q1 FY27: revenue $387M (+6% year over year), operating margin 12.8%, net earnings $29.5M, operating cash flow $26.1M. The chart follows the revenue to costs, profit and cash.
Questions
Does Phibro Animal Health beat its guidance?
Phibro Animal Health gave guidance in 3 earnings releases on file since May 6, 2026. Of 1 guided period since reported, it met or beat its own guidance once (100%). Revenue: 1 of 1, on average +2.6% against the guided midpoint.
How often does Phibro Animal Health raise guidance?
Its earnings releases raised guidance once and lowered it once since May 6, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.